THROMBOCYTHEMIA, ESSENTIAL
Clinical trials for THROMBOCYTHEMIA, ESSENTIAL explained in plain language.
Never miss a new study
Get alerted when new THROMBOCYTHEMIA, ESSENTIAL trials appear
Sign up with your email to follow new studies for THROMBOCYTHEMIA, ESSENTIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial extends hope for patients with rare blood disorders
Disease control Recruiting nowThis study continues treatment for 400 people with rare blood cancers who are already benefiting from the drug bomedemstat in earlier trials. Its main goal is to collect long-term safety information and see how well the drug continues to control the disease over time. The study i…
Matched conditions: THROMBOCYTHEMIA, ESSENTIAL
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Massive 5,000-Person study launches to map the journey of rare blood cancers
Knowledge-focused Recruiting nowThis is a long-term observational study aiming to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. who have been diagnosed with an MPN for at least five years, collecting information from …
Matched conditions: THROMBOCYTHEMIA, ESSENTIAL
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC